» Articles » PMID: 38306451

[Obstructive Sleep Apnea in Cardiology Clinical Practice. Epidemiology, Diagnosis, and Treatment. Observational, Cross-sectional, Retrospective Study]

Overview
Date 2024 Feb 2
PMID 38306451
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the clinical-epidemiological characteristics, diagnostic feasibility of home respiratory polygraphy and treatment of patients with suspected obstructive sleep apnea (OSA) at cardiovascular risk.

Methods: An observational, cross-sectional, descriptive study was conducted in patients seen in a cardiology outpatient service with suspected OSA, from January 2015 to December 2019. The information was obtained from medical records, and a descriptive statistical analysis was applied to this information.

Results: 138 files were reviewed; only 8% of the home respiratory polygraphs were discarded, because they did not meet the required quality standards. It was demonstrated that 89% suffered from OSA, 60% moderate to severe; in men after 50 years of age. The main cardiovascular risk factors was hypertension (89%). The most prevalent heart disease was hypertension (52%). Cardiovascular pharmacological treatment was improved in 82% of the cases. Cardiac rehabilitation in 30%, noninvasive mechanical ventilation 41%, fixed modality 33%, and self-adjustable 9%, all with telemetry.

Conclusions: The prevalence and severity of OSA is higher in the presence of risk or established cardiovascular disease. In the presence of clinical suspicion, it is feasible to confirm the diagnosis with home respiratory poligrafy due to the level of precision and the lower infrastructure required. Greater involvement of the cardiologist in the diagnosis and treatment of this disorder is necessary due to the significant risk of cardiovascular disease it represents.

References
1.
Patil S, Ayappa I, Caples S, Kimoff R, Patel S, Harrod C . Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2019; 15(2):335-343. PMC: 6374094. DOI: 10.5664/jcsm.7640. View

2.
Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

3.
Turnbull C . Intermittent hypoxia, cardiovascular disease and obstructive sleep apnoea. J Thorac Dis. 2018; 10(Suppl 1):S33-S39. PMC: 5803045. DOI: 10.21037/jtd.2017.10.33. View

4.
Kline C, Hillman C, Sheppard B, Tennant B, Conroy D, Macko R . Physical activity and sleep: An updated umbrella review of the 2018 Physical Activity Guidelines Advisory Committee report. Sleep Med Rev. 2021; 58:101489. PMC: 8338757. DOI: 10.1016/j.smrv.2021.101489. View

5.
Fan J, Wang X, Ma X, Somers V, Nie S, Wei Y . Association of Obstructive Sleep Apnea With Cardiovascular Outcomes in Patients With Acute Coronary Syndrome. J Am Heart Assoc. 2019; 8(2):e010826. PMC: 6497330. DOI: 10.1161/JAHA.118.010826. View